Work

Phase 2 Study of Ponatinib in Patients (Pts) with Advanced Gastrointestinal Stromal Tumors (Gist) After Failure of Tyrosine Kinase Inhibitor (Tki) Therapy: Early Results

Year: 2014

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu354.6

Authors: M.C. Heinrich, M. von Mehren, G.D. Demetri, J. Fletcher, J. Sun, J.G. Hodgson, V.M. Rivera, C.D. Turner, S. George

Institutions: Oregon Health & Science University, Portland VA Medical Center, OHSU Knight Cancer Institute, Fox Chase Cancer Center, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Brigham and Women's Hospital, ARIAD Pharmaceuticals (United States)

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2278555352

FWCI: 0.573

Cites:

Cited by: 7

Related to: 10